Antares Pharma Announces Issuance of Patent for VIBEX Device Platform

Antares Pharma

today announced the issuance of U.S. Patent number 8,562,564, entitled “Prefilled Syringe Jet Injector”. This patent adds to a comprehensive portfolio of patents and applications that are intended to protect Antares' auto injector technology and product pipeline including the VIBEX® Medi-Jet™ device and the VIBEX® Quick Shot™ (QS) technology. This new patent is designed to protect the use of medicament containing prefilled syringe based auto-injectors, such as those used in OTREXUP™ and QS T (in development for testosterone deficiency). Paul K. Wotton, Ph.D., President and Chief Executive Officer, stated, “We continue to pursue an aggressive long-term strategy to create comprehensive intellectual property coverage for our device technology